Zhejiang CONBA Pharmaceutical Co.,Ltd. Stock: price and insider trades · China
康恩贝
No insider purchase over the last 90 days. The latest, by 金祖成, was filed 30 Nov 2021.
Zhejiang CONBA Pharmaceutical Co.,Ltd.: what insiders have been doing
Every trade that managers of Zhejiang CONBA Pharmaceutical Co.,Ltd. disclose to SSE / SZSE (CSRC) is tracked on this page. The company sits in the Health Care sector. The past year has been quiet: not a single insider filing for Zhejiang CONBA Pharmaceutical Co.,Ltd. The previous disclosure was published on 30 November 2021.
Over the whole record (from 2021), the tally stands at 2 purchases and no sales.
In the same sector, recent insider purchases at Dynavox Group AB and Vetoquinol SA also feature in our signals. Every figure here comes from the filings published by SSE / SZSE (CSRC) and describes the past, not future prices; it is not investment advice.
Since the insiders bought
- +12.6%Entry CN¥4.30 · Close at T+365 CN¥4.84
- +12.6%Entry CN¥4.30 · Close at T+365 CN¥4.84
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2025FY ended December 2025 · cache
About Zhejiang CONBA Pharmaceutical Co.,Ltd.
康恩贝 is a company in the health and pharmaceutical sector, listed on the Shanghai Stock Exchange. It focuses on the research, development, and production of medicines and health products.
Recent ranked signals in the same sector
Purchases our model currently ranks for the recommendations list.
All recommendations
